“CureVac Stock Soared 249% on Its First Day of Trading…”
August 17, 2020
“Shares of CureVac, the German biotech specializing in the messenger RNA technology that is the basis of many of the leading Covid-19 vaccine programs, is set to soar on its second day of trading.
CureVac shares (ticker: CVAC) were up 42% in premarket trading Monday after climbing 249.4% on Friday, but were up just 23% at 10:37 a.m. The company priced its initial public offering at $16 per share, began trading at $44 per share on Friday, and was priced at $79.33 per share in the premarket hours on Monday…”
https://finance.yahoo.com/m/e08e3afd-f174-3d65-a320-bde27ff16888/curevac-stock-soared-249-on.html